Cargando…
Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled
Autores principales: | Goletti, Delia, Cantini, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944951/ https://www.ncbi.nlm.nih.gov/pubmed/33657299 http://dx.doi.org/10.1056/NEJMe2034982 |
Ejemplares similares
-
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
por: Cantini, Fabrizio, et al.
Publicado: (2020) -
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
por: Cantini, Fabrizio, et al.
Publicado: (2020) -
In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
por: Petrone, Linda, et al.
Publicado: (2021) -
Unmet need for COVID-19 therapies in community settings
por: The Lancet Infectious Diseases
Publicado: (2021) -
Novel lipid-modifying therapies addressing unmet needs in cardiovascular disease
por: Kosmas, Constantine E, et al.
Publicado: (2019)